[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623491":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":37,"centralContacts":42,"locations":47,"responsibleParty":80,"collaborators":82,"id":87,"slug":88,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":91,"acronym":29,"eligibilityCriteria":92,"healthyVolunteers":89,"sex":93,"minAge":94,"maxAge":95,"enrollmentInfo":96,"targetDuration":29,"studyType":99,"phases":100,"briefSummary":103,"conditions":104,"keywords":107,"overallStatus":50,"whyStopped":29,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Applied Biology, Inc.","INDUSTRY",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"DA-020","ACTIVE_COMPARATOR","Topical DA-020 Solution",[13],"Drug: DA-020",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Topical Placebo Solution",[19],"Drug: Placebo",{"label":21,"type":10,"description":21,"interventionNames":22},"DA-020 and Hyperforin (1.5%)",[23],"Drug: DA-020 and Hyperforin",[25,30,33],{"type":26,"name":9,"description":27,"armGroupLabels":28,"otherNames":29},"DRUG","7mL application of DA-020 (Topical Oxymetazoline)",[9],null,{"type":26,"name":15,"description":31,"armGroupLabels":32,"otherNames":29},"Topical placebo solution",[15],{"type":26,"name":34,"description":35,"armGroupLabels":36,"otherNames":29},"DA-020 and Hyperforin","7mL application of DA-020 (Topical Oxymetazoline) and Hyperforin (1.5%)",[21],[38],{"name":39,"affiliation":40,"role":41},"Andy Goren, MD","University of Rome G. Marconi","STUDY_DIRECTOR",[43],{"name":39,"role":44,"phone":45,"phoneExt":29,"email":46},"CONTACT","16507040850","clinicalstudies@appliedbiology.com",[48,67],{"facility":49,"status":50,"city":51,"state":29,"zip":29,"country":52,"countryCode":53,"cosmosGeoPoint":54,"geoPoint":59,"contacts":60},"Hospital Samel","RECRUITING","Manaus","Brazil","BR",{"type":55,"coordinates":56},"Point",[57,58],-60.025,-3.10194,{"lat":58,"lon":57},[61,65],{"name":62,"role":44,"phone":63,"phoneExt":29,"email":64},"Daniel Fonseca, MD","+55 92 2129-2200","clinicalstudies@appliedbilogy.com",{"name":62,"role":66,"phone":29,"phoneExt":29,"email":29},"PRINCIPAL_INVESTIGATOR",{"facility":68,"status":69,"city":70,"state":29,"zip":29,"country":71,"countryCode":72,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"University of Rome (\"G. Marconi\")","NOT_YET_RECRUITING","Rome","Italy","IT",{"type":55,"coordinates":74},[75,76],12.51133,41.89193,{"lat":76,"lon":75},[79],{"name":39,"role":44,"phone":45,"phoneExt":29,"email":46},{"type":81,"investigatorFullName":29,"investigatorTitle":29,"investigatorAffiliation":29,"oldNameTitle":29,"oldOrganization":29},"SPONSOR",[83,85],{"name":84,"class":6},"Daniel Alain, Inc.",{"name":86,"class":6},"Follea International Limited","100623491","phase-1-clinical-study-of-da-020-for-the-treatment-of-chemotherapy-induced-alopecia-100623491",false,"NCT07397325","Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia","Inclusion Criteria:\n\n* Diagnosed with stage I or stage II breast cancer\n* Scheduled but not begun, at least 4 cycles of taxane and\u002For anthracycline-based chemotherapy.\n* Ages 18-65\n* Able to give informed consent\n\nExclusion Criteria:\n\n* Resting blood pressure outside the range of 105-140\u002F 55-99\n* Uncontrolled or severe hypertension\n* Female pattern hair loss or hair loss disorder\n* Folliculitis\n* Scalp psoriasis\n* Seborrheic dermatitis\n* Inflammatory scalp conditions such as lichen planopillaris\n* Subjects wearing wigs prior to chemotherapy\n* Use of MAO inhibitors\n* Unable to provide consent or make allotted clinical visits","FEMALE","18 Years","65 Years",{"count":97,"type":98},60,"ESTIMATED","INTERVENTIONAL",[101,102],"PHASE1","PHASE2","Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia",[105,106],"Chemotherapy Induced Alopecia","Chemotherapy Side Effects",[105,108],"Chemotherapy Alopecia","2026-08-20",{"date":111,"type":112},"2026-08-21","ACTUAL",{"date":114,"type":112},"2026-05-16",{"date":116,"type":98},"2027-03-05",{"name":5,"class":6},2]